drugset / Trial / NCT01224795
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study to evaluate the efficacy and safety of a single dose of intravenous peramivir versus placebo in adolescents and adults with acute uncomplicated influenza.
Timeline
- Start
- 2010-10
- Primary completion
- 2010-11
- Completion
- 2010-11
Outcome
Met primary endpoint
release “Both the 300 mg and 600 mg single dose peramivir groups demonstrated non-inferiority for the primary endpoint” biocryst.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 10 mg/kg | Intravenous |
| Subject | PERAMIVIR ANHYDROUS | Small molecule | 600 mg | Intravenous |